Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real-world study Journal:Diabetes, Obesity and Metabolism | 5-Nov-2024 | ||
Serum thrombospondin-2 level changes with liver stiffness improvement in patients with type 2 diabetes Journal:Clinical Endocrinology | 21-Dec-2023 | ||
| 15-Apr-2023 |